Available medications

The Affordable Medicines program is designed to provide patients with essential medications at a reduced cost or free of charge. Our website offers articles covering the main aspects of this program, including its structure, funding mechanisms, and impact on public health.

Learn how the program helps improve access to important medicines to treat chronic and common diseases such as diabetes, asthma and cardiovascular disorders. Learn about the eligibility criteria for drugs and the process for reimbursement through public or private insurance. Learn about the interactions between government agencies, pharmacies, and drug manufacturers within the program. Discuss the advantages and disadvantages of the Affordable Medicines program, examining its impact on improving access to care and reducing costs for patients. Get tips for patients on how to get the most out of the program, including information on how and where to get medications and what documents are required to participate in the program.

From October 8, the Register of medical devices subject to reimbursement will become effective

The list of medical products subject to reimbursement under the “Affordable Medicines” program was supposed to start working on October 1. However, the Ministry of Health by its order No. 1717 dated 30.09.2023 postponed the start of reimbursement under the updated list to October 8

From October 8, the Register of medical devices subject to reimbursement will become effective Read More »

A pilot project on pharmaceutical insurance starts

According to MoH estimates, Ukrainians annually spend about 60 billion UAH on medicines, and more than 50% of them come from medicines without proven efficacy and unjustified prescriptions. There are drugs that are not included in the “Affordable Drugs” program and their cost is not reimbursed under the reimbursement program. Voluntary pharmaceutical insurance will provide

A pilot project on pharmaceutical insurance starts Read More »

Scroll to Top